血糖变异性：一种独立于糖化血红蛋白的糖尿病并发症危险因素。 - Suppr

Suppr

超能文献

Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.

作者信息

Brownlee Michael, Hirsch Irl B

出版信息

JAMA. 2006 Apr 12;295(14):1707-8. doi: 10.1001/jama.295.14.1707.

DOI:10.1001/jama.295.14.1707

PMID:16609094

Abstract

摘要

相似文献

Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications.

JAMA. 2006 Apr 12;295(14):1707-8. doi: 10.1001/jama.295.14.1707.

Assessing glycemia in diabetes using self-monitoring blood glucose and hemoglobin A1c.

JAMA. 2006 Apr 12;295(14):1688-97. doi: 10.1001/jama.295.14.1688.

Hemoglobin A1c and Permissive Hyperglycemia in Patients in the Intensive Care Unit with Diabetes.

Crit Care Clin. 2019 Apr;35(2):289-300. doi: 10.1016/j.ccc.2018.11.010. Epub 2019 Jan 24.

[Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].

Rinsho Byori. 2014 Jan;62(1):45-52.

Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Diabetes Technol Ther. 2017 May;19(S2):S16-S26. doi: 10.1089/dia.2017.0029.

Relationship between oxidative stress and blood glucose fluctuations evaluated with daily glucose monitoring in children with type 1 diabetes mellitus.

J Pediatr Endocrinol Metab. 2016 Apr;29(4):435-9. doi: 10.1515/jpem-2015-0212.

Dealing with high blood sugar. Closely monitor your glucose levels to protect yourself from the dangerous sugar highs of hyperglycemia.

Health News. 2005 Aug;11(8):11-2.

Use of glycated hemoglobin and microalbuminuria in the monitoring of diabetes mellitus.

Evid Rep Technol Assess (Summ). 2003 Jul(84):1-6.

Self-monitoring of blood glucose--an overview.

Diabetes Technol Ther. 2013 Feb;15 Suppl 1:S3-12. doi: 10.1089/dia.2013.1501.

Glycemic Variability, Oxidative Stress, and Impact on Complications Related to Type 2 Diabetes Mellitus.

Curr Diabetes Rev. 2021;17(7):e071620183816. doi: 10.2174/1573399816666200716201550.

引用本文的文献

A retrospective analysis of the prognostic implications of glycemic variability on all-cause mortality in critically ill patients with mitral valve disease.

Front Endocrinol (Lausanne). 2025 Jul 14;16:1620762. doi: 10.3389/fendo.2025.1620762. eCollection 2025.

Mitochondrial dynamics in diabetic peripheral neuropathy: Pathogenesis, progression, and therapeutic approaches.

Medicine (Baltimore). 2025 Jul 18;104(29):e42748. doi: 10.1097/MD.0000000000042748.

Strengthening monocarboxylate transporters by adiponectin receptor agonist ameliorates diabetic peripheral neuropathy.

Cell Commun Signal. 2025 Jul 16;23(1):342. doi: 10.1186/s12964-025-02326-5.

Association between eGDR and MASLD and liver fibrosis: a cross-sectional study based on NHANES 2017-2023.

Front Med (Lausanne). 2025 May 30;12:1579879. doi: 10.3389/fmed.2025.1579879. eCollection 2025.

Natural therapy proposed for the management of diabetic peripheral neuropathy (DPN).

Inflammopharmacology. 2025 May 30. doi: 10.1007/s10787-025-01790-2.

Mediation effect of body mass index on the association between glycated albumin and 10-year atherosclerotic cardiovascular disease risk in Hunan residents of China: a retrospective cross-sectional study.

BMJ Open. 2025 May 24;15(5):e092714. doi: 10.1136/bmjopen-2024-092714.

Hybrid closed loop and intensive insulin delivery technology: Reviewing the effect of improving 'time in range' glucose levels on diabetic retinopathy.

Eye (Lond). 2025 Apr;39(6):1028-1030. doi: 10.1038/s41433-025-03730-4. Epub 2025 Feb 20.

Prognostic value of glycaemic variability for mortality in critically ill atrial fibrillation patients and mortality prediction model using machine learning.

Cardiovasc Diabetol. 2024 Nov 26;23(1):426. doi: 10.1186/s12933-024-02521-7.

Effects of insulin glargine U300 versus insulin degludec U100 on glycemic variability, hypoglycemia, and diet evaluated by continuous glucose monitoring in type 1 diabetes: a retrospective cross-sectional study.

Kaohsiung J Med Sci. 2024 Dec;40(12):1086-1094. doi: 10.1002/kjm2.12909. Epub 2024 Nov 26.

Association of time in range with cognitive impairment in middle-aged type 2 diabetic patients.

BMC Endocr Disord. 2024 Nov 8;24(1):241. doi: 10.1186/s12902-024-01772-5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验